Illustris Pharmaceuticals Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-03. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Andrew Khim Hirschberg | Director | Palo Alto, CA |
| Mark Prygocki | Director | Palo Alto, CA |
| Jonah Khim Shacknai | Director | Palo Alto, CA |
| Siak Khim Tan | Director | Irvine, CA |
| Jacob M Waugh | Director | Palo Alto, CA |
| Jaehoon M Lee | Executive Officer | Palo Alto, CA |
| Mark Prygocki | Executive Officer | Palo Alto, CA |
| Gloria M Vasquez | Executive Officer | Palo Alto, CA |
| Jacob M Waugh | Executive Officer | Palo Alto, CA |